Back to search

Switzerland· 68556002

Emge Biomed Forte, Pulver zur Herstellung einer Lösung zum Einnehmen

A magnesium citrate product, registered in Switzerland by Biomed AG and dispensed under Swissmedic category D. The same ATC class is registered in 8 of our 19 countries.

Cat D (Swissmedic)ATC A12CC04

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedEmge Biomed Forte, Pulver zur Herstel…ATCA12CC04REGISTER NO.68556002PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Magnesium citrate is registered in 8 of 19 countries.

Countries holding a registration under ATC A12CC04 (magnesium citrate), each read from that country’s own register.

  • This record: Switzerland
  • 5 of them publish a price we can compare per daily dose

Magnesium citrate · ATC A12CC04

8 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of magnesium citrate costs, country by country.

Normalised to the WHO defined daily dose (2 g), so markets compare like for like.

  • Switzerland: $6.99 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Magnesium citrate · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.99
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Manufacturer
Biomed AG
Country
Switzerland (CH)
ATC code
A12CC04
ATC class
Magnesium citrate
Defined daily dose
2 g, O
Swissmedic category
D
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

305 interactions on record for magnesium citrate.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Magnesium citrate · interactions on record

305 records

  • 4 severe
  • 287 moderate
  • 1 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe

13 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2262f8e-957d-4511-8837-bb4b32015bf3
GET /v1/drugs/f2262f8e-957d-4511-8837-bb4b32015bf3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about magnesium citrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.